Replicel Life Sciences Inc REPCF:OTCPK

RT Quote | Exchange | USD
Last | 05/17/21 EDT
0.339UNCH (UNCH)
Volume
220
52 week range
0.07 - 0.47

...

Loading . . .
  • Open0.339
  • Day High0.339
  • Day Low0.339
  • Prev Close0.339
  • 52 Week High0.47
  • 52 Week High Date02/08/21
  • 52 Week Low0.07
  • 52 Week Low Date09/10/20

Key Stats

  • Market Cap9.29M
  • Shares Out29.95M
  • 10 Day Average Volume12,099.73
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change99.29

KEY STATS

  • Open0.339
  • Day High0.339
  • Day Low0.339
  • Prev Close0.339
  • 52 Week High0.47
  • 52 Week High Date02/08/21
  • 52 Week Low0.07
  • 52 Week Low Date09/10/20
  • Market Cap9.29M
  • Shares Out29.95M
  • 10 Day Average Volume12,099.73
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change99.29

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-7.66
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Replicel Life Sciences Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Replicel Life Sciences Inc is a Canada-based regenerative medicine company. It develops autologous cell therapies that treat functional cellular deficits. Its product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile...
David Hall
Non-Executive Chairman
R. Lee Buckler
President
Simon Ma
Chief Financial Officer
Address
570 Granville St Suite 900
Vancouver, BC
V6C 3P1
Canada